Literature DB >> 15546224

A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate.

Manfred Stommel1, Margot E Kurtz, J C Kurtz, Charles W Given, Barbara A Given.   

Abstract

This study mapped the trajectory of depression and its components (depressive mood, somatic expression of depression, and lack of positive affect) for 1 year after an initial cancer diagnosis, revealing the complex nature of the psychological response to the cancer experience. The analysis was based on 4 waves of panel data from 860 older patients with incident breast, colon, lung, or prostate cancer. Predictors of depressive symptoms included cancer site; stage; comorbidities; sociodemographic characteristics; and indicators of physical functioning, symptom severity, and treatment. Patients' overall depressive symptoms declined, especially depressive mood and somatic indicators. By contrast, the sense of well-being did not recover; in fact, it would have deteriorated without improvements in physical functioning and physical symptoms. The present findings show the importance of psychological assessments and symptom management during cancer treatment. ((c) 2004 APA, all rights reserved).

Entities:  

Mesh:

Year:  2004        PMID: 15546224     DOI: 10.1037/0278-6133.23.6.564

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  38 in total

1.  Predictors of depressive symptoms among breast cancer patients during the first year post diagnosis.

Authors:  Rebecca J Schlegel; Mark A Manning; Lisa A Molix; Amelia E Talley; B Ann Bettencourt
Journal:  Psychol Health       Date:  2011-06-16

2.  Clergy-laity support and patients' mood during serious illness: a cross-sectional epidemiologic study.

Authors:  Judith C Hays; Laura Wood; Karen Steinhauser; Maren K Olson; Jennifer H Lindquist; James A Tulsky
Journal:  Palliat Support Care       Date:  2011-09

3.  Change in quality of life in Chinese women with breast cancer: changes in psychological distress as a predictor.

Authors:  Wing S Wong; Richard Fielding
Journal:  Support Care Cancer       Date:  2007-01-05       Impact factor: 3.603

Review 4.  Older adults and cancer treatment.

Authors:  Barbara Given; Charles W Given
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

5.  Prevalence of severe depressive symptoms increases as death approaches and is associated with disease burden, tangible social support, and high self-perceived burden to others.

Authors:  Siew Tzuh Tang; Jen-Shi Chen; Wen-Chi Chou; Kuan-Chia Lin; Wen-Cheng Chang; Chia-Hsun Hsieh; Chiao-En Wu
Journal:  Support Care Cancer       Date:  2015-05-03       Impact factor: 3.603

6.  Facets of spirituality as predictors of adjustment to cancer: relative contributions of having faith and finding meaning.

Authors:  Betina Yanez; Donald Edmondson; Annette L Stanton; Crystal L Park; Lorna Kwan; Patricia A Ganz; Thomas O Blank
Journal:  J Consult Clin Psychol       Date:  2009-08

7.  Resilience in the year after cancer diagnosis: a cross-lagged panel analysis of the reciprocity between psychological distress and well-being.

Authors:  Wai Kai Hou; John Hiu Ming Lam
Journal:  J Behav Med       Date:  2013-02-20

8.  Prognostic association of demographic and clinical factors with the change rates of symptoms and depression among patients with hepatocellular carcinoma.

Authors:  Jyh-Jou Chen; Sheng-Shiung Huang; In-Fun Li; Kuan-Pin Lin; Shiow-Luan Tsay
Journal:  Support Care Cancer       Date:  2019-04-03       Impact factor: 3.603

9.  Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment.

Authors:  Nancy E Avis; Beverly Levine; Michelle J Naughton; L Douglas Case; Elizabeth Naftalis; Kimberly J Van Zee
Journal:  Breast Cancer Res Treat       Date:  2013-04-16       Impact factor: 4.872

10.  Pain is associated with continuing depression in cancer survivors.

Authors:  Patricia M Bamonti; Jennifer Moye; Aanand D Naik
Journal:  Psychol Health Med       Date:  2018-06-14       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.